Haemophilus

(redirected from Haemophilus influenzae type b)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.
Related to Haemophilus influenzae type b: Haemophilus influenzae type B vaccine

Haemophilus

A genus of gram-negative, pleomorphic bacteria that are facultative anaerobes and are nonmotile and non-spore-forming.

Haemophilus influenzae was the first of the species to be isolated and is considered the type species. It was originally recovered during the influenza pandemic of 1889 and for a time was believed to be the causative agent of influenza; thus it was called the influenza bacillus. However, when this fallacy became apparent, the organism was renamed, still reflecting the historical association with influenza.

Haemophilus species are distinguished by a number of criteria. Strains of H. influenzae can be separated into encapsulated and nonencapsulated forms. Encapsulated strains express one of six biochemically and antigenically distinct capsular polysaccharides that are designated serotypes a through f. Nonencapsulated strains are referred to as nontypable. See Influenza, Meningitis

Haemophilus influenzae is a human-specific pathogen that inhabits the upper respiratory tract and is acquired by exposure to airborne droplets or contact with respiratory secretions. Nontypable strains can be isolated from the nasopharynx of up to 80% of normal children and adults at any given time, usually in association with asymptomatic colonization. Overall, these organisms are the leading cause of exacerbations of chronic bronchitis, and the second most common etiology of acute otitis media and sinusitis. On occasion, nontypable H. influenzae causes invasive disease such as meningitis, septicemia, endocarditis, epiglottitis, or septic arthritis. Invasive disease occurs most often in neonates and in patients with underlying immunodeficiency, especially when abnormalities in humoral immunity are present.

Encapsulated strains of H. influenzae are present in the nasopharynx of only 2–5% of children and an even smaller percentage of adults. Historically, H. influenzae type b strains were the primary cause of childhood bacterial meningitis and a majority of other bacteremic diseases in children. However, in recent years the incidence of disease due to H. influenzae type b has plummeted in the United States and other developed countries, reflecting the routine use of H. influenzae conjugate vaccines. These vaccines provide effective protection against disease due to H. influenzae type b but fail to protect against non-type b strains.

Haemophilus aphrophilus, H. haemolyticus, H. parahaemolyticus, H. parainfluenzae, and H. segnis are members of the normal flora in the human oral cavity and oropharynx and have low pathogenic potential. Among these species, H. parainfluenzae is the most common pathogen and has been reported in association with a variety of diseases.

Strains of H. influenzae are increasingly resistant to a wide variety of antibiotics. Accordingly, an extended-spectrum cephalosporin is generally recommended for empiric treatment of serious disease. See Antibiotic, Drug resistance, Medical bacteriology

Haemophilus

[hē′mä·fə·ləs]
(microbiology)
A genus of gram-negative coccobacilli or rod-shaped bacteria of uncertain affiliation; cells may form threads and filaments and are aerobic or facultatively anaerobic; strictly blood parasites.
References in periodicals archive ?
Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.
Figure 6 10: Worldwide - Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 - 2011
Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial.
Susceptibility and genetic relatedness of invasive Haemophilus influenzae type b in Italy.
market for pediatric vaccines -- to protect the very young from such diseases as Haemophilus influenzae type b, diphtheria, tetanus, pertussis, polio and hepatitis B.
Invasive Haemophilus influenzae type b infections in children hospitalized in Hong Kong, 1986-1990.
GlobalData, the industry analysis specialist, has released its new report, Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019.
Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska.
Conjugate vaccines and carriage of Haemophilus Influenzae type b.
This is combined with a Hib pellet targeting Haemophilus influenzae type B and applied by deep intramuscular injection.
to immunize against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib) -
Immunizations: Includes hepatitis B (HepB), diphtheria-tetanus-pertussis (DTaP), haemophilus influenzae type b (Hib), inactivated polio (IPV), measles-mumps-rubella (MMR), varicella, pneumococcal (PCV), hepatitis A, and influenza.

Full browser ?